Consider raising AstraZeneca vax age threshold, says top haematologist
The severity of clot cases should prompt a rethink for people in their 50s, he says
Australia needs to "look closely" at whether the threshold age for receiving the AstraZeneca COVID-19 vaccine should be raised to 60 in the wake of severe cases of thrombosis with thrombocytopenia syndrome, a leading expert on the rare disorder says.
Professor Huyen Tran.
The Australian Technical Advisory Group on Immunisation's (ATAGI) advice is that the Pfizer vaccine is preferred for people under 50 because of